Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07322042 · ClinicalTrials.gov registry record · NA

Evaluating Screening Adherence Between Moment for Parents App and Attention Control

A NA study of Mental Health Screening Adherence, sponsored by Poisera.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT07322042: Recruiting NA study of Mental Health Screening Adherence, sponsored by Poisera.

NCT07322042 is a NA study of Mental Health Screening Adherence that is actively recruiting participants, run by Poisera. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07322042, a NA study of Mental Health Screening Adherence, is actively recruiting participants, sponsored by Poisera.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

Mental health challenges, such as depression and anxiety, are the most common medical complications during pregnancy and after childbirth. Many women experience these symptoms, yet half are never screened, let alone diagnosed. When mental health concerns go unnoticed, they can affect a mother's well-being, her birth experience, and her child's development. When identified early, these conditions are treatable. However, current healthcare practices often fail to screen women consistently, and many women do not feel comfortable discussing emotional struggles with healthcare providers. This study will test whether a mobile app called Moment for Parents can help pregnant and postpartum women complete mental health screenings more regularly. The app includes educational articles, guided reflections, and mood check-ins that help women explore their feelings in a private, supportive environment. The app also includes a chatbot that guides them through short lessons about motherhood, stress, relationships, and emotional well-being. These conversations are designed to feel friendly and relatable, like talking with a knowledgeable companion rather than filling out a medical form. The investigators expect that this more personal experience may make it easier for women to notice and track changes in their mental health and encourage them to complete regular screeners. The study will enroll 160 women who are pregnant or within the first year after giving birth. Participants will be randomly assigned to one of two groups: Intervention group: Uses the full Moment for Parents app, including the interactive chatbot. Control group: Uses a simplified version of the app with weekly articles but no chatbot. Both groups will receive mental health screenings through the app over a 12-week period. These screenings include standard, widely used questionnaires that measure symptoms of depression and anxiety. If a participant's answers show signs of concerning symptoms, such as depressi

Primary Outcome

Mental health screening adherence will be measured as the total number of completed PHQ-9 and GAD-7 screenings delivered through the Moment for Parents app during the 12-week study period. Screening opportunities occur bi-weekly and are recorded passively by the application backend, allowing precise tracking of whether a participant completed each scheduled screening. Adherence will be compared across study arms using count-based analysis methods to determine whether the interactive chatbot incr

Interventions

  • BEHAVIORAL Perinatal Psychoeducation Articles
  • BEHAVIORAL Bi-weekly Perinatal Mental Health Screening
  • BEHAVIORAL Chatbot-Guided Journaling
  • BEHAVIORAL Perinatal-Focused Meditations
  • BEHAVIORAL Themed Perinatal Learning Pathways

Study Locations (1)

Michigan

  • Remote/Virtual Participation - Ann Arbor

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2026-02-05
Est. Completion 2026-08
Phase NA
Poisera

1 total trials

What NCT07322042 shows while recruiting

NCT07322042 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Mental Health Screening Adherence appearing as the primary indexed condition, and to 5 interventions - of which Perinatal Psychoeducation Articles is the first listed.

NCT07322042 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT07322042 about?

NCT07322042 is a clinical study titled "Evaluating Screening Adherence Between Moment for Parents App and Attention Control". Mental health challenges, such as depression and anxiety, are the most common medical complications during pregnancy and after childbirth. Many women experience these symptoms, yet half are never screened, let alone diagnosed. When mental health concerns go unnoticed, they can affect a mother's well...

What is the current status of trial NCT07322042?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2026-02-05. Estimated completion is 2026-08.

What conditions does trial NCT07322042 study?

This clinical trial studies the following conditions: Mental Health Screening Adherence.

What interventions are being tested in trial NCT07322042?

The interventions under investigation include: Perinatal Psychoeducation Articles (BEHAVIORAL), Bi-weekly Perinatal Mental Health Screening (BEHAVIORAL), Chatbot-Guided Journaling (BEHAVIORAL), Perinatal-Focused Meditations (BEHAVIORAL), Themed Perinatal Learning Pathways (BEHAVIORAL).

Who is sponsoring clinical trial NCT07322042?

This trial is sponsored by Poisera, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07322042 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT07322042's enrollment target sits among peer trials

160 628th of 2000 higher than 1,348 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07322042, the US trial registry maintained by the National Library of Medicine. NCT07322042 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.